Medfinder
Back to blog

Updated: January 18, 2026

Jublia Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar and graph showing Jublia shortage update and availability

Is Jublia in shortage in 2026? Get the latest update on Jublia availability, why patients struggle to access it, and what to do if you can't fill your prescription.

If you've been prescribed Jublia (efinaconazole 10% topical solution) for toenail fungus and have struggled to fill your prescription, you're not alone. Many patients report difficulty finding Jublia at their pharmacy — but the reason isn't a classic drug shortage. Here's what's actually happening with Jublia availability in 2026 and what you can do about it.

Is Jublia Currently in Shortage?

As of 2026, Jublia is NOT listed on the FDA's drug shortage database. Ortho Dermatologics (Bausch Health) continues to manufacture and distribute Jublia in the United States. Supply of the medication itself has been stable.

However, "available" and "accessible" are very different things. Despite no official shortage, Jublia remains one of the most access-restricted topical prescription medications in the United States due to its cost, insurance coverage hurdles, and pharmacy program limitations.

Why Do Patients Feel Like Jublia Is in Shortage?

There are several structural reasons that Jublia feels difficult to access, even without a manufacturing shortage:

Price barrier: At $923–$1,055 per 4 mL bottle without insurance, most patients can't afford it out of pocket. Since a full treatment course lasts 48 weeks and may require 12 or more refills, the cost is unsustainable.

Insurance coverage gaps: Many commercial plans require prior authorization or step therapy before covering Jublia. Medicare Part D typically doesn't cover it. Medicaid coverage is inconsistent across states.

Pharmacy program restrictions: The Rx Access Program — which is the most effective way to reduce cost — is only valid at Walgreens and participating independent pharmacies. If your nearest or preferred pharmacy isn't one of these, accessing the savings is complicated.

Limited generic availability: While the FDA has approved generic efinaconazole, commercial availability remains limited in 2026. Broad generic competition isn't expected until around 2029–2030.

Has Jublia Ever Had a Real Shortage?

There have been no major FDA-reported manufacturing shortages of Jublia since its approval in 2014. The accessibility issues patients experience are structural — cost and coverage barriers — rather than supply chain problems. This distinguishes Jublia from drugs like certain ADHD medications or GLP-1 agonists that have faced genuine manufacturing shortages in recent years.

What to Do If You Can't Access Jublia in 2026

If you're having trouble filling your Jublia prescription, here are the key steps to take:

Check the manufacturer savings program. Visit OrthoRxAccess.com to see if you qualify. Cash-pay patients can get Jublia for $75 per 4 mL bottle at Walgreens or participating independents. Medicare/Medicaid patients are not eligible.

Use GoodRx or SingleCare. These discount coupons bring the cash price to roughly $727–$741 per 4 mL bottle at major chain pharmacies.

Appeal your insurance denial. If your plan requires step therapy, ask your prescriber to document why alternatives are inappropriate for you, or to submit a letter of medical necessity.

Apply for patient assistance. The Bausch Health Patient Assistance Program may provide Jublia at no cost for eligible low-income uninsured patients.

Ask about alternatives. Generic oral terbinafine is more effective and dramatically less expensive. Generic ciclopirox nail lacquer is a cheap topical option.

What's the Outlook for Jublia Availability?

The primary patent protecting Jublia is expected to expire in 2028, with broader generic competition projected to arrive around 2029–2030. When generic efinaconazole becomes widely available, prices are expected to drop by 30–50% or more. Until then, patients face the full cost of a brand-name specialty medication.

For now, the best path forward is to use every available savings tool and to work with your prescriber to find the most effective and affordable treatment option for your specific situation.

How medfinder Helps Patients Access Their Medication

medfinder calls pharmacies near you to find which ones can fill your Jublia prescription. Instead of spending time calling pharmacy after pharmacy, you share your medication details and location and medfinder texts you the results. For more tips, see our guide on how to find Jublia in stock near you.

Frequently Asked Questions

No, Jublia (efinaconazole) is not on the FDA drug shortage list in 2026. The medication is in stable supply from its manufacturer, Ortho Dermatologics (Bausch Health). The access challenges most patients face are due to high cost, limited insurance coverage, and pharmacy program restrictions — not a manufacturing shortage.

The FDA has already approved generic efinaconazole from manufacturers including Teva and Umedica, but commercial availability is limited in 2026. The primary Jublia patent expires in 2028, and broader generic competition is expected around 2029–2030, which should significantly reduce prices.

First, ask if they can order it — many pharmacies can special-order medications within a few days. You can also check other nearby pharmacies, particularly Walgreens locations (which participate in the manufacturer savings program). medfinder can call pharmacies on your behalf to find one that can fill your prescription.

Many insurance plans require step therapy — meaning they want you to try and fail on cheaper alternatives like ciclopirox or terbinafine first. Medicare Part D typically does not cover Jublia. If your plan denied coverage, your doctor can submit a prior authorization request or letter of medical necessity explaining why standard alternatives are not appropriate for you.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Jublia also looked for:

Terbinafine (Lamisil)Ciclopirox (Penlac)Tavaborole (Kerydin)Itraconazole (Sporanox)

31,889 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,889 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?